Not logged in A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950) Bhatia, Aarti; Chen, Zhengjia; Zhang, Yuji; Bruce, Justine Yang; Arnold, Susanne; Kaur, Varinder; Riess, Jonathan W.; Fenton, Moon; Burtness, Barbara; Saba, Nabil F.; Tara, Harold; Steuer, Conor E.; Shin, Dong M.; Wasp, Garrett; Davis, Thomas H.; Patel, Malini; Schmitz, John C.; Bhateja, Priyanka; Diavolitsis, Virginia; Zandberg, Dan P.; Mitchell, Darrion L.; Kiesel, Brian F.; Kunos, Charles; Gore, Steven D.; Carducci, Michael; Beumer, Jan H.; Owonikoko, Taofeek K. Share Save
Share Save
Share Save
Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer Alese, Olatunji B.; Harvey, Robert Donald; Wu, Christina; Hitron, Elise; Collins, Hannah; Scott, Suzanne; Steuer, Conor; Bilen, Mehmet A.; Carthon, Bradley C.; Switchenko, Jeffrey M.; Ramalingam, Suresh S.; Owonikoko, Taofeek K. Share Save
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair (vol 39, pg 4798, 2020) Koyen, Allyson E.; Madden, Matthew Z.; Park, Dongkyoo; Minten, Elizabeth V.; Kapoor-Vazirani, Priya; Werner, Erica; Pfister, Neil T.; Haji-Seyed-Javadi, Ramona; Zhang, Hui; Xu, Jie; Deng, Nikita; Duong, Duc M.; Pecen, Turner J.; Frazier, Zoe; Nagel, Zachary D.; Lazaro, Jean-Bernard; Mouw, Kent W.; Seyfried, Nicholas T.; Moreno, Carlos S.; Owonikoko, Taofeek K.; Deng, Xingming; Yu, David S. Share Save
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer Sands, Jacob M.; Champiat, Stephane; Hummel, Horst-Dieter; Paulson, Kelly G.; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P.; Carlisle, Jennifer W.; Choudhury, Noura J.; Clarke, Jeffrey M.; Gadgeel, Shirish M.; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C. M.; Lammers, Philip E.; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K. Share Save
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers Mahalingam, Devalingam; Owonikoko, Taofeek K.; Delpassand, Ebrahim; Mulcahy, Mary F.; Kalyan, Aparna; Ulahannan, Susanna; Cheung, Kin; Izumi, Yasayuki; Johansen, Mary; Madden, Timothy; Shimoyama, Susumu; Subach, Ruth Ann; Suzuki, Takeaki; Wages, David S.; Wheeler, Catherine; Richardson, Debra L. Share Save
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer Ahn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok; Dziadziuszko, Rafal; Wolf, Juergen; Blackhall, Fiona; Reck, Martin; Alvarez, Jean Bustamante; Hummel, Horst-Dieter; Dingemans, Anne-Marie C.; Sands, Jacob; Akamatsu, Hiroaki; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa L.; Huang, Shuang; Mukherjee, Sujoy; Minocha, Mukul; Jiang, Tony; Martinez, Pablo; Anderson, Erik S.; Paz-Ares, Luis Share Save
IDeate-Lung03: A Phase Ib/II study of ifinatamab deruxtecan (I-DXd) plus atezolizumab (atezo) with or without carboplatin (carbo) as first-line (1L) induction or maintenance in patients (pts) with extensive stage (ES) small cell lung cancer (SCLC) Rudin, C. M.; Salkeni, M. A.; Gutierrez, M.; Hayashi, H.; Thompson, J.; Arca, M.; Hirose, D.; Singh, J.; Turner, J.; Zhang, Y.; Owonikoko, T. K. Share Save
DareonTM-5: An open-label phase 2 trial of BI 764532, a DLL3-targeting T-cell engager, in patients (pts) with relapsed/refractory small cell lung cancer or other neuroendocrine carcinomas Gambardella, Valentina; Greystoke, Alastair; Reck, Martin; Liu, Meiruo; Mueller, Martha; Duenzinger, Ulrich; Bergsland, Emily B.; Owonikoko, Taofeek Share Save
Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC) Navarro, Alejandro; Ahn, Myung-Ju; Stevenson, James; Peled, Nir; Kutiel, Talia Shentzer; Huemer, Florian; Kim, Dong-Wan; Casulleras, Maria Jove; Khattak, Adnan; Kowalski, Dariusz; Leighl, Natasha B.; de Marinis, Filippo; Lips, Carolin; Niu, Jiaxin; Huang, Mo; Zhao, Bin; El-Osta, Hazem; Owonikoko, Taofeek Share Save
Share Save
Share Save
Share Save
DareonTM-5: An open-label Phase II trial of BI 764532, a DLL3-targeting T cell engager, in patients with relapsed/refractory small cell lung cancer or other neuroendocrine carcinomas Gambardella, Valentina; Greystoke, Alastair; Reck, Martin; Liu, Meiruo; Mueller, Martha; Duenzinger, Ulrich; Bergsland, Emily B.; Owonikoko, Taofeek Share Save
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer Ahn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok; Dziadziuszko, Rafal; Wolf, Juergen; Blackhall, Fiona; Reck, Martin; Bustamante Alvarez, Jean; Hummel, Horst-Dieter; Dingemans, Anne-Marie C.; Sands, Jacob; Akamatsu, Hiroaki; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa L.; Huang, Shuang; Mukherjee, Sujoy; Minocha, Mukul; Jiang, Tony; Martinez, Pablo; Anderson, Erik S.; Paz-Ares, Luis Share Save
Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+tumors: Focus on Asian pts Kuboki, Y.; Gambardella, V.; Capdevila Castillon, J.; Alese, O. B.; Morgensztern, D.; Sayehli, C. M.; Sanmamed, M. F.; Arriola, E.; Wolf, J.; Owonikoko, T. K.; Studeny, M.; Bouzaggou, M.; Song, E.; Wermke, M. Share Save
Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study Paz-Ares, L.; Ahn, M-J.; Felip, E.; Handzhiev, S.; Korantzis, I.; Izumi, H.; Ohashi, K.; Majem Tarruella, M.; Wolf, J.; Reck, M.; Hummel, H-D.; Blackhall, F.; Dingemans, A-M. C.; Owonikoko, T. K.; Ramalingam, S. S.; Sands, J.; Jiang, T.; Mukherjee, S.; Anderson, E.; Cho, B. C. Share Save
Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study Paz-Ares, L.; Ahn, M-J.; Felip, E.; Handzhiev, S.; Korantzis, I.; Izumi, H.; Ohashi, K.; Majem, M.; Wolf, J.; Reck, M.; Hummel, H-D.; Blackhall, F.; Dingemans, A-M. C.; Owonikoko, T. K.; Ramalingam, S. S.; Sands, J.; Jiang, T.; Mukherjee, S.; Anderson, E.; Cho, B. C. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
